ERBB2 and breast carcinoma: Given the fact that limitations are unavoidable and all studies face that, as a potential limitation in the present study, although most studies used the same cut-off values since we had no access to raw data, we could not define an ideal threshold for the serum-HER2 test in the diagnosis of breast cancer.